Efficacy of a Special Oral Nutritional Supplement on Nutritional Status of Malnourished Elderly Patients
Nutri-PA
1 other identifier
interventional
40
1 country
2
Brief Summary
The aim of this study is to evaluate in malnourished elderly patients the nutritional efficacy of a new nutritional supplement enriched in different specific pharmaco nutrients (leucine, micronutrients, omega-3) appearing in the form of a cake of high caloric density and palatability. The primary endpoint is the outcome of fat-free mass measured by multiple frequence bio-impedance analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2009
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2009
CompletedFirst Submitted
Initial submission to the registry
April 7, 2009
CompletedFirst Posted
Study publicly available on registry
April 8, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedOctober 16, 2013
October 1, 2013
2.2 years
April 7, 2009
October 15, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
outcome of fat-free mass measured by multiple frequence bio-impedance analysis
28 days
Secondary Outcomes (1)
safety of oral supplementation
28 days
Study Arms (2)
1
EXPERIMENTALNutri-Energie ®, a cake of high caloric density and palatability, twice a day for 4 weeks, in addition to an enriched diet.
2
ACTIVE COMPARATORClinutren 1.5 ® standard isocaloric commercially available supplement, twice a day for 4 weeks, in addition to an enriched diet.
Interventions
Nutri-Energie ® is a new cake of high caloric density and palatability, enriched in different specific pharmaco nutrients.
Clinutren 1.5 ®, isocaloric commercially available supplement, twice a day for 4 weeks, in addition to an enriched diet
Eligibility Criteria
You may qualify if:
- Both male and female participants
- Moderately malnourished defined by whether:
- \< BMI \< 21
- to 10% body weight loss in the last past 6 months.
- Buzby index between 83.5 and 97.5 (calculated with weight loss and albumin)
- With or without any factors increasing malnutrition (insufficient caloric intakes, long term treatment)
- Justifying hospitalisation in rehabilitation unit
You may not qualify if:
- Age \< 70 years old or \> 90 years old
- Surgical affection involving a surgery in the next 10 days
- Contraindicated oral intakes due to digestive injury
- Total parenteral nutrition
- Ulcer or infection existing
- Malignant hemopathy
- Hepatic insufficiency (TP \< 30%)
- Swallowing difficulties limiting solid oral intakes
- Kidney failure (renal dialysis)
- Expected survival \> 3 months
- Impossibility to give an informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Hospitalier de Dieppe
Dieppe, 76200, France
UHRouen
Rouen, 76031, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pierre DECHELOTTE, PR
University Hospital, Rouen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2009
First Posted
April 8, 2009
Study Start
April 1, 2009
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
October 16, 2013
Record last verified: 2013-10